To ensure that a patient’s test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at support@genedx.com to determine how to proceed.
Chief Legal Officer
Heidi Chen serves as the Chief Legal Officer and Corporate Secretary at GeneDx, where she oversees the company’s legal, compliance, and policy functions. Her responsibilities span corporate governance, intellectual property, regulatory matters, federal policy, and compliance, among others.
With over 30 years of experience, Heidi’s career has been fueled by her passion for pushing boundaries and pioneering innovations that drive meaningful improvements in health outcomes.
Prior to joining GeneDx, Heidi was the General Counsel at Zoetis for nearly 12 years, a role she assumed following the company’s spinoff from Pfizer in 2013. During her tenure at Zoetis, she was instrumental in building the company’s legal department and establishing essential processes to support the company’s rapid growth. Heidi also oversaw global security, enterprise risk management, M&A, litigation and all corporate governance. In addition to her legal oversight, she also led operational strategy for a specialized human health diagnostics segment within the Zoetis business.
Prior to the spinoff, Heidi held a variety of leadership positions on Pfizer’s legal team and worked across regulatory, compliance, litigation, licensing and risk management. She began her career with roles at Hughes & Hubbard and Clifford Chance. Heidi holds a J.D. from Cornell Law School and a B.S. from Yale University.
